ClinicalTrials.gg
Not yet recruitingNCT07773493Updated Nov 4, 2026

A Mobile Informatics Solution to Assist Caregivers in Care Coordination and Monitoring Social Engagement

An interventional study of Social Reminder System in Memory Disorders, Mild Cognitive Impairment and Dementia, sponsored by University of Minnesota. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by University of Minnesota · Not applicable, Interventional, and Supportive care

Updated Nov 4, 2026Start date movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will evaluate the Social Reminder System, a mobile informatics system designed to support persons with memory concerns and their care partners. The system is intended to aid social integration for persons with memory concerns and improve care coordination and reduce caregiver burden among caregivers.

Researchers will enroll 100 persons with memory concerns and their care partners. Half of the dyads will be randomly assigned to receive the Social Reminder System technology for a 6-month period, and the other half will be randomly assigned to the usual care control group. Participants will complete baseline, 3-month, and 6-month surveys. A subset of participants who receive the technology will also be asked to complete a semi-structured interview after the 6-month survey.

Read the detailed description

The Social Reminder System has two goals. The first is to aid in the social integration of persons with memory concerns. The second is to improve care coordination and reduce caregiver burden among caregivers. Following a randomized control trial design, the study will assess the impact of the Social Reminder System on both persons with memory concerns and their care partners.

The Social Reminder System app is designed to provide memory prompts to persons with memory concerns on an in-home tablet before and during social visits. Individuals who are part of a person with memory concerns' trusted circle may download a free smartphone app and save a photo of themselves, their names, and familial relationship description that are shared with the person with memory concerns' display. When trusted circle members are within a 10-meter range of the tablet, the person with memory concerns receives a notification that a visitor is in range. The notification includes a photo of the visitor, the visitor's name, and information about their relationship to the person with memory concerns. Reminders continue to appear on the tablet throughout the visit and cease once the visitor is out of range.

The phase 2b technology also allows the person with memory concerns to designate a primary caregiver. For security reasons and to promote care coordination, the care partner will receive a log of visitors who opted in as trusted circle members. The log will include names, dates, and beginning and ending times of each visit.

A total of 100 dyads, consisting of persons with memory concerns and their care partners, will be enrolled. Half of the dyads will be randomly assigned to the Social Reminder System intervention group and half to an attention control group. Participants will complete baseline, 3-month, and 6-month surveys. The baseline survey will be administered before exposure to the intervention or attention control. Follow-up surveys will be administered 3 months and 6 months after enrollment.

The study will also include semi-structured interviews with a subset of dyads randomly assigned to receive the Social Reminder System. Interviews will take place after completion of the final 6-month follow-up survey and will focus on overall reactions to the technology, perceived barriers to engagement with the technology, and short- and long-term outcomes of engagement with the technology that may have been missed in the survey instruments.

02

Conditions studied

  • Memory Disorders
  • Mild Cognitive Impairment
  • Dementia
  • Social Isolation
  • Caregiver Burden

Keywords

  • Social Reminder System
  • SRS
  • Persons with memory concerns
  • Social engagement
  • Mobile health
  • Care coordination
  • Alzheimer's disease and related dementias
  • Mild-to-moderate memory impairment
  • Caregiver stress
03

In context

Memory Disorders

373 studies on the registry are indexed under Memory Disorders; 67 are open to participants now.

This study's planned enrollment of 200 is above the median of 72 across 298 interventional studies indexed under Memory Disorders.

Browse Memory Disorders studies →

Lead sponsor

University of Minnesota is the lead sponsor of 1,216 studies on the registry; 197 are open to participants now.

Of its 136 completed or terminated interventional studies of FDA-regulated products, 95 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Persons with memory concerns must be English speaking.
  • Persons with memory concerns must self-report a healthcare provider visit due to memory concerns or memory related diagnosis by a physician or other qualified health care provider consistent with having mild-to-moderate memory impairment.
  • Persons with memory concerns must be over the age of 65.
  • Persons with memory concerns must be able to formally consent or assent to participate in the study.
  • Persons with memory concerns must have internet access.
  • Care partners of persons with memory concerns must speak English.
  • Care partners must be 18 years of age and over.
  • Care partners must self-identify as the primary caregiver for the person with memory concerns.
  • Care partners must indicate a willingness to use the Social Reminder System as well as to being randomized to a control group.
  • Care partners must have a mobile phone with internet access in order to install and use the care partner app.

Exclusion criteria

Exclusion Criteria:

  • Those who do not meet the criteria above will be excluded.
  • Persons with memory concerns with severe or no dementia are not eligible.
  • Individuals who score below 6 and above 24 on the TICS-40 will not be eligible.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Social Reminder System

    Dyads randomly assigned to this arm will receive the Social Reminder System technology for a 6-month period. The Social Reminder System app is designed to provide memory prompts to persons with memory concerns on an in-home tablet before and during social visits. Care partners will also receive a log of visitors to promote care coordination.

    Behavioral: Social Reminder System

  • No intervention
    Usual Care Control

    Dyads randomly assigned to this arm will receive usual care control. The attention control group will receive a 3-month contact call and a 6-month contact call from the research coordinator. Free information resources, such as brochures or websites of the Alzheimer's Association, may be provided.

Interventions

  • BehavioralSocial Reminder System

    The Social Reminder System app is designed to provide memory prompts to persons with memory concerns on an in-home tablet before and during social visits. Individuals who are part of a person with memory concerns' trusted circle may download a free smartphone app and save a photo of themselves, their names, and familial relationship description that are shared with the person with memory concerns' display. When trusted circle members are within a 10 meter range of the tablet, the person with memory concerns receives a notification that a visitor is in range. Reminders continue to appear on the tablet throughout the visit and cease once the visitor is out of range. The care partner will also receive a log of visitors, including names, dates, and beginning and ending times of each visit.

06

What researchers measure

Primary outcomes

  1. Change in Social Interaction Frequency and Quality

    Change in frequency and quality of social interactions reported by persons with memory concerns and care partners, including in-person visits, phone calls, mail and letters, and computer-mediated communication.

    Time frame: Baseline to 6 months

  2. Change in Pleasant Events and Social Engagement as Assessed by the Pleasant Events Schedule-Alzheimer's Disease

    Change in pleasant events and social engagement for persons with memory concerns, assessed using the Pleasant Events Schedule-AD.

    Time frame: Baseline to 6 months

  3. Change in Social Support Score

    Change in social support among persons with memory concerns and care partners, assessed using a five-item social support scale.

    Time frame: Baseline to 6 months

  4. Change in Loneliness

    Change in loneliness among persons with memory concerns and care partners, assessed using the UCLA Loneliness Scale.

    Time frame: Baseline to 6 months

  5. Change in Caregiver Burden

    Change in caregiver burden among care partners, assessed using the Zarit Burden Interview.

    Time frame: Baseline to 6 months

  6. Change in Role Captivity Score

    Change in role captivity among care partners, assessed using a 4-item role captivity scale.

    Time frame: Baseline to 6 months

  7. Change in Role Overload Score

    Change in role overload among care partners, assessed using a 3-item role overload scale.

    Time frame: Baseline to 6 months

  8. Change in Anxiety as Assessed by the Hospital Anxiety and Depression Scale

    Change in anxiety among persons with memory concerns and care partners, assessed using the Hospital Anxiety and Depression Scale.

    Time frame: Baseline to 6 months

  9. Change in Depression as Assessed by the Hospital Anxiety and Depression Scale

    Change in depression among persons with memory concerns and care partners, assessed using the Hospital Anxiety and Depression Scale.

    Time frame: Baseline to 6 months

Secondary outcomes

  1. Perceived Function, Utility, and Barriers to Engagement With the Social Reminder System

    Semi-structured interviews will assess overall reactions to the Social Reminder System, perceived barriers to engagement with the technology, and short- and long-term outcomes of engagement with the technology that may have been missed in the survey instruments.

    Time frame: Up to 1 month after completion of the 6-month follow-up survey

  2. Change in Service Utilization Among Persons With Memory Concerns

    Change in service utilization among persons with memory concerns, including nursing home, assisted living, other residential care, hospital stays, and emergency department visits.

    Time frame: Baseline to 6 months

  3. Change in Negative Health Transitions Among Persons With Memory Concerns

    Change in negative health transitions among persons with memory concerns, including falls and wandering events, assessed by care partner report.

    Time frame: Baseline to 6 months

  4. Change in Quality of Life as Assessed by the Adapted Quality of Life-Alzheimer's Disease Measure

    Change in quality of life for persons with memory concerns and care partners, assessed using the adapted Quality of Life-Alzheimer's Disease measure.

    Time frame: Baseline to 6 months

  5. Change in Community Engagement as Assessed by the 15-Item Community Engagement Scale

    Change in community engagement among persons with memory concerns and care partners, assessed using a 15-item scale evaluating frequency, duration, and location of trips outside the home.

    Time frame: Baseline to 6 months

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Mar 2028, 14 months later.

Of 129 non-industry interventional studies with no phase under Memory Disorders, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 53. This study's planned 14 months is below that.

Counting every sponsor, half of 138 studies reached it within 35 months; a quarter within 17 and three quarters within 53.

Start moved once since we started tracking on Sep 25, 2026: Nov 2026 → Jan 2027, on Nov 4, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 13, 2026
First posted
Aug 19, 2026
StartEst.
Jan 16, 2027was Nov 2026
Primary completionEst.
Mar 2028
CompletionEst.
Jun 2028
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Nov 1, 2026→Jan 16, 2027
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Start date Nov 1, 2026→Jan 16, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07773493
Responsible party
Sponsor
First posted
Aug 19, 2026
Start date
Jan 16, 2027 (estimated)
Primary completion
Mar 2028 (estimated)
Completion
Jun 2028 (estimated)
Last update
Nov 4, 2026

Study contacts

Hannah Wheeler
Contact
hwheeler@umn.edu
612-624-2642
Jude Mikal, PhD
principal investigator · University of Minnesota

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion